Gianluca Franceschini: Precision Medicine Is Only Truly Effective If It Is Inclusive
Gianluca Franceschini, Director of the Research and Training Center on Integrated Therapies in Breast Neoplasms, Full Professor of General Surgery and Director of the Master’s Program in Integrated Therapies for Female Oncological Pathologies at Catholic University of the Sacred Heart, shared a post on LinkedIn:
“Precision Medicine is truly effective only if it is inclusive
We had the honor of hosting Prof. Olufunmilayo Olopade from the University of Chicago at the The Catholic University of the Sacred Heart and the Gemelli University Hospital for the Faculty Lecture series, promoted by Dean Prof. Alessandro Sgambato.
A special thanks to Prof. Emilio Bria for organizing the event and inviting me, and to Prof. Giampaolo Tortora.
It was a privilege for me to introduce Prof. Olopade alongside them.
Her lecture on hereditary breast cancer and global genomics reminded us of a crucial point: precision medicine only works if it represents all populations.
A scientific message, but also a call for cultural and social responsibility.
Let’s work together to build increasingly inclusive precision breast care!”
Discover the latest in Hemostasis Today.
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD
-
Oct 17, 2026, 02:34Raising Awareness of Blood Clots During and After Pregnancy – Thrombosis UK
-
Oct 17, 2026, 02:33Alaa Salamat: Our Research Accepted for Publication at ASH 2026
-
Oct 17, 2026, 02:32Mohammed Al Sharif: Discussing Factor XIII Testing and Its Clinical Significance
-
Oct 17, 2026, 02:31Joanna Popiolek-Kalisz: Talking about Novel Pharmacotherapy for Hypertension at CV Prevention and Intervention